SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000819050-22-000124
Filing Date
2022-07-29
Accepted
2022-07-29 16:07:56
Documents
14
Period of Report
2022-07-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bbi-20220728.htm   iXBRL 8-K 35812
2 EX-3.1 a202207288kex31.htm EX-3.1 128252
6 bbi-20220728_g1.jpg GRAPHIC 6568
  Complete submission text file 0000819050-22-000124.txt   348752

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bbi-20220728.xsd EX-101.SCH 1909
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bbi-20220728_lab.xml EX-101.LAB 26155
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bbi-20220728_pre.xml EX-101.PRE 13590
8 EXTRACTED XBRL INSTANCE DOCUMENT bbi-20220728_htm.xml XML 11748
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21088 | Film No.: 221120840
SIC: 2836 Biological Products, (No Diagnostic Substances)